Assenagon Asset Management S.A. Has $1.88 Million Stock Holdings in Ingevity Co. (NYSE:NGVT)

Assenagon Asset Management S.A. reduced its stake in shares of Ingevity Co. (NYSE:NGVT) by 1.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 46,223 shares of the company’s stock after selling 777 shares during the period. Assenagon Asset Management S.A. owned approximately 0.13% of Ingevity worth $1,884,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of NGVT. First Horizon Advisors Inc. grew its holdings in shares of Ingevity by 45.9% in the 3rd quarter. First Horizon Advisors Inc. now owns 862 shares of the company’s stock valued at $34,000 after acquiring an additional 271 shares in the last quarter. KBC Group NV raised its holdings in Ingevity by 50.8% during the third quarter. KBC Group NV now owns 1,574 shares of the company’s stock worth $61,000 after acquiring an additional 530 shares in the last quarter. Blue Trust Inc. boosted its position in Ingevity by 179.6% during the third quarter. Blue Trust Inc. now owns 2,505 shares of the company’s stock valued at $98,000 after purchasing an additional 1,609 shares during the last quarter. nVerses Capital LLC bought a new position in Ingevity in the third quarter valued at approximately $113,000. Finally, Nisa Investment Advisors LLC increased its position in shares of Ingevity by 27.3% during the 3rd quarter. Nisa Investment Advisors LLC now owns 3,880 shares of the company’s stock worth $151,000 after purchasing an additional 831 shares during the last quarter. Institutional investors own 91.59% of the company’s stock.

Wall Street Analyst Weigh In

Separately, BMO Capital Markets increased their price objective on Ingevity from $40.00 to $47.00 and gave the company a “market perform” rating in a report on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, Ingevity presently has an average rating of “Moderate Buy” and a consensus price target of $52.17.

Ingevity Stock Performance

Shares of NGVT stock opened at $47.91 on Friday. The company has a market capitalization of $1.74 billion, a price-to-earnings ratio of -3.08 and a beta of 1.65. The company has a debt-to-equity ratio of 6.52, a quick ratio of 1.04 and a current ratio of 1.76. Ingevity Co. has a 52 week low of $30.90 and a 52 week high of $56.29. The company has a 50-day simple moving average of $44.15 and a 200 day simple moving average of $40.86.

Ingevity (NYSE:NGVT) last posted its earnings results on Tuesday, October 29th. The company reported $1.10 EPS for the quarter, beating the consensus estimate of $0.60 by $0.50. The company had revenue of $376.90 million for the quarter, compared to the consensus estimate of $376.95 million. Ingevity had a positive return on equity of 24.46% and a negative net margin of 38.11%. The firm’s revenue for the quarter was down 15.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.21 earnings per share. On average, sell-side analysts predict that Ingevity Co. will post 2.75 earnings per share for the current year.

Ingevity Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.